Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Carlo Zivelonghi , Giulia Geremia , Michele Pighi , et al Added: 3 years ago
Drug-eluting stents (DESs) have significantly improved the effectiveness of percutaneous revascularisation procedures. Since the initial experiences with the first devices, now called ‘first-generation’, DESs have proved very effective in reducing restenosis.1–3 The ‘second-generation’ DESs were conceived to have at least the same standards of efficacy than their predecessors, but with improved… View more

Intervention
ECR Hernadez
Author(s): Dae-Hyun Lee , José M de la Torre Hernández Added: 3 years ago
When Andreas Grüntzig introduced balloon coronary angioplasty in 1977 it represented the first alternative to coronary artery bypass graft surgery. However, balloon dilatation had inherent limitations – including elastic recoil and vessel closure in the acute phase, as well as negative remodelling and restenosis in the late phase – which limited its applicability and further expansion. In the… View more

Intervention
Craig Thompson
Job title: Director
Personal History Dr. Thompson is based in Hartford Connecticut, where he works as Director of Cardiac Catheterization and Interventional Cardiology for Hartford HealthCare. Academic History Dr. Thompson holds an undergraduate degree from the University of Southern Mississippi, a medical degree from the University of Mississippi and a Masters of Medical Science in clinical investigation… View more
EuroPCR 22: SYNERGY™ Non-inferior to BioMatrix NeoFlex in OCT SORT-OUT VIII
Author(s): Michael Mæng Added: 1 year ago
In this short interview, Dr Matthew Mæng (Aarhus University Hospital, DK) joins us to discuss the outcomes of a follow-up study on OCT SORT-OUT VIII (NCT02253108), originally presented at EuroPCR 2022. This follow-up study aimed to compare the outcomes of Boston Scientific's SYNERGY™ stent to the BioMatrix NeoFlex stent. Findings suggest that the SYNERGY™ stent was non-inferior to the BioMatrix… View more

Intervention
Author(s): Adnan Kastrati Added: 3 years ago
Drug-eluting stents (DES) are the standard percutaneous treatment strategy in patients with coronary artery disease (CAD). Their use has further reduced the incidence of restenosis and repeat revascularisation in single vessel de novo disease. These stents have bioactive coatings that, through a complex mechanism, allow the release of various anti-inflammatory and anti-proliferative drugs at high… View more

Intervention
Author(s): Ricardo Seabra-Gomes Added: 3 years ago
It took great courage around 30 years ago to tackle stenotic lesions within a diseased coronary artery using the percutaneous approach in an unanaesthetised human being. Since then, unbelievable progress and research have been taking place worldwide in a continuum that never seems to end. Percutaneous coronary intervention (PCI) is, for the responsible interventional cardiologist, not only an… View more

Intervention
Author(s): Ashok Seth Added: 3 years ago
“I do not know what I may appear to the world, but to myself I seem to have been only like a boy playing on the sea-shore, diverting myself in now and then finding a smoother pebble or a prettier shell than ordinary, whilst the great ocean of truth lay all undiscovered before me.” Sir Isaac Newton Advances in Percutaneous Coronary Intervention – An Overview Over the last 10 years, the… View more

Intervention
Author(s): Christian Fink , Henrik J Michaely , Stefan O Schoenberg Added: 3 years ago
Contrast-enhanced magnetic resonance angiography (ce-MRA) has become an established and routinely used imaging modality and has largely replaced invasive diagnostic digital subtraction angiography (DSA). There have been ongoing technical developments in magnetic gradient hardware, coil design and pulse sequence design for ce-MRA, resulting in an increased spatial and temporal resolution. The… View more

Imaging & Diagnostics
Author(s): Savio D’Souza , Giuseppe Ferrante , Pawel Tyczynski , et al Added: 3 years ago
Percutaneous coronary intervention (PCI) deploying metallic stents is now a standard and routine procedure for the treatment of flow-limiting coronary stenosis in patients with ischaemic heart disease and is an alternative to surgery. Stents were invented to overcome limitations of balloon angioplasty coronary dissections, acute and subacute elastic recoil, intimal hyperplasia and negative vessel… View more

Intervention
Drug-eluting Balloons in Coronary Artery Disease
Author(s): Anouar Belkacemi , Pierfrancesco Agostoni , Michiel Voskuil , et al Added: 3 years ago
In the past few decades, major progress has been made in the percutaneous treatment of coronary artery disease. Initially, the emergence of balloon angioplasty offered an alternative option for coronary revascularisation. However, abrupt closure and restenosis caused by elastic recoil, neointimal hyperplasia and late remodelling were major drawbacks of balloon angioplasty.1 The use of drug… View more

Imaging & Diagnostics

Prevention & Chronic Conditions